Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Process International is a private industrial biotechnology and engineering company focused on biorefinery process development, biomass conversion, and energy optimization rather than human therapeutics. The company develops and commercializes technologies for producing cellulosic sugars, biofuels, nanocellulose, lignin-derived materials, and related bio-based products from non-food biomass such as woodchips and agricultural residues. It also provides engineering, procurement, construction management, process integration, carbon and energy optimization, and proprietary simulation software for biorefineries, pulp and paper, and chemical industries. Its operations include U.S. headquarters in Atlanta and technical operations in Greece, with an R&D center supporting pretreatment, hydrolysis, fermentation, and product recovery work. For a biotech analyst, this is best classified as an active industrial biotech/platform and engineering company, not a healthcare or drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Process International.